HeartGenetics recognised as the Digital Health Company of the Year – Portugal
HeartGenetics was one of the winners of the “Global Health & Pharma’s Healthcare & Pharmaceutical Awards 2021”.
HeartGenetics, an INESC-ID startup and member of the IST Spin-off Community, was recognised as the Digital Health Company of the Year -Portugal. The Portuguese startup was one of the winners of the “Global Health & Pharma’s Healthcare & Pharmaceutical Awards 2021”, delivered by the Global Health & Pharma (GHP).
GHP hosts the Healthcare & Pharmaceutical Awards for a sixth consecutive year and honour the innovation, determination and outstanding levels of care demonstrated by those responsible for bringing to the sector new ideas and products that help the development of the sector.
These awards are based on various criteria such as business performance, business growth, longevity and customer feedback.
HeartGenetics aims to use genetic information to improve everyone’s health and well-being. Internationally recognised in the areas of molecular biology, genetics, information technology and artificial intelligence, the Digital Health Company is able to extract genetic data from a simple saliva sample and generate a report containing very useful and easy-to-read information.